Sivik Global Healthcare LLC Boosts Position in Agilent Technologies, Inc. (A)
Sivik Global Healthcare LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 31.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 105,000 shares of the medical research company’s stock after purchasing an additional 25,000 shares during the period. Agilent Technologies comprises approximately 2.3% of Sivik Global Healthcare LLC’s portfolio, making the stock its 18th largest position. Sivik Global Healthcare LLC’s holdings in Agilent Technologies were worth $6,741,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Dupont Capital Management Corp acquired a new stake in Agilent Technologies in the 3rd quarter valued at approximately $101,000. Balentine LLC grew its stake in shares of Agilent Technologies by 2.9% in the second quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after acquiring an additional 50 shares in the last quarter. Sun Life Financial INC grew its stake in shares of Agilent Technologies by 26,144.4% in the second quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after acquiring an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC grew its stake in shares of Agilent Technologies by 92.3% in the second quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Parallel Advisors LLC grew its stake in shares of Agilent Technologies by 5.3% in the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after acquiring an additional 131 shares in the last quarter.
In other Agilent Technologies news, CFO Didier Hirsch sold 20,000 shares of the company’s stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $64.00, for a total value of $1,280,000.00. Following the sale, the chief financial officer now owns 183,002 shares of the company’s stock, valued at $11,712,128. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Boon Hwee Koh sold 4,500 shares of the company’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total transaction of $286,335.00. The disclosure for this sale can be found here. Insiders sold 107,709 shares of company stock worth $7,195,576 in the last ninety days.
WARNING: “Sivik Global Healthcare LLC Boosts Position in Agilent Technologies, Inc. (A)” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.watchlistnews.com/sivik-global-healthcare-llc-boosts-position-in-agilent-technologies-inc-a/1721918.html.
Shares of Agilent Technologies, Inc. (A) traded down $1.22 during trading hours on Thursday, hitting $68.69. 3,041,700 shares of the stock were exchanged, compared to its average volume of 1,857,755. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $70.81. The company has a quick ratio of 2.76, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $22,499.00, a PE ratio of 29.50, a price-to-earnings-growth ratio of 2.76 and a beta of 1.27.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.05. Agilent Technologies had a net margin of 14.89% and a return on equity of 15.05%. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period in the previous year, the business posted $0.59 earnings per share. The business’s revenue was up 7.0% compared to the same quarter last year. equities research analysts forecast that Agilent Technologies, Inc. will post 2.57 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be issued a $0.149 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.87%. The ex-dividend date of this dividend is Friday, December 29th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is 25.24%.
Several research firms have commented on A. Deutsche Bank AG set a $75.00 price target on shares of Agilent Technologies and gave the stock a “buy” rating in a research note on Tuesday. J P Morgan Chase & Co boosted their price target on shares of Agilent Technologies to $75.00 and gave the stock an “overweight” rating in a research note on Tuesday. Barclays PLC boosted their price target on shares of Agilent Technologies from $67.00 to $71.00 and gave the stock an “overweight” rating in a research note on Tuesday. Cowen and Company restated a “hold” rating and issued a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday. Finally, Zacks Investment Research downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Monday, October 30th. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $68.20.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.